The TP53 Arg72Pro and MDM2 309G > T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
2009
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
22
References
19
Citations
NaN
KQI